At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Reduction of Bladder Injection Pain With Belladonna Opiate Suppository: A Randomized, Double-Blind, Placebo-Controlled Trial (ROBIN Trial)
In Brief
A Phase 4 clinical trial evaluating Onabotulinumtoxin A (BoNT), belladonna, and 3 other interventions for Overactive Bladder and 3 related conditions. Completed, enrolled 26 participants across 2 sites.
Detailed Summary
The purpose of this study is to test whether using belladonna \& opiate suppositories (B\&Os) can improve patient discomfort during Onabotulinumtoxin A (BoNT) injection into the bladder for treatment of overactive bladder, neurogenic detrusor overactivity, or interstitial cystitis.
Study Details
Timeline
Interventions
Part of dosage of the compounded active B\&O suppository of belladonna 16.2mg and morphine 7.5mg.
Part of dosage of the compounded active B\&O suppository of belladonna 16.2mg and morphine 7.5mg.
matching placebo to B\&O suppository
belladonna 16.2mg and morphine 7.5mg